Erisyon's new fluorosequencing technology will revolutionize the way we detect, treat, and track genetic diseases such as cancer, Parkinson's disease, and Alzheimer's - just to name a few of the big ones. By running billions of simultaneous digital experiments with uncompromised sensitivity using AI computing power, this new lab device will provide faster breakthroughs for researchers working on DNA sequencing. Herbst worked with Erisyon to create an intelligent brand that clearly communicates the science as well as the floor standing device design, worthy of the light speed technology within.
"Poised to have an outsized impact on science in the coming year." - Nature